An update on renovascular hypertension

Current Cardiology Reports

Volumn 7, Issue 6, 2005, Pages 405-411

  Senitko, Martin ^b   Fenves, Andrew Z ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ATHEROSCLEROSIS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIAGNOSTIC ACCURACY; DIGITAL SUBTRACTION ANGIOGRAPHY; ECHOGRAPHY; FIBROMUSCULAR DYSPLASIA; HUMAN; KIDNEY ARTERY STENOSIS; KIDNEY BLOOD FLOW; KIDNEY FUNCTION TEST; KIDNEY PERFUSION; LABORATORY DIAGNOSIS; MAGNETIC RESONANCE ANGIOGRAPHY; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRESSURE GRADIENT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; REVASCULARIZATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

EID: 28244465693     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-005-0057-8     Document Type: Review

References (73)

1. Berglund G, Andersson O, Wilhelmsen L: Prevalence of primary and secondary hypertension: studies in a random population sample. Br Med J 1976, 2:554-556.
2. Detection, evaluation, and treatment of renovascular hypertension. Final report. Working Group on Renovascular Hypertension. Arch Intern Med 1987, 147:820-829.
3. Anderson GH Jr., Blakeman N, Streeten DH: The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens 1994, 12:609-615.
4. Bech K, Hilden T. The frequency of secondary hypertension. Acta Med Scand 1975, 197:65-69.
5. Goldblatt H, Lynch J, Hanzal RE, Summerville WW: Studies on experimental hypertension I: the production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 1934, 59:347-379.
6. May AG, Van de Berg L, DeWeese JA, Rob CG: Critical arterial stenosis. Surgery 1963, 54:250-259.
7. Giancoli DC: Flow in Tubes: Poiseuille's equation, blood flow. In Physics: Principles with Applications. Edited by Giancoli DC. Upper Saddle River: Prentice Hall; 1998:295-296.
8. Brunner HR, Kirshman JD, Sealey JE, Laragh JH: Hypertension of renal origin: evidence for two different mechanisms. Science 1971, 174:1344-1346.
9. Textor SC, Novick A, Mujais SK, et al.: Responses of the stenosed and contralateral kidneys to [Sar1, Thr8] AII in human renovascular hypertension. Hypertension 1983, 5:796-804.
10. Korner PI: Cardiovascular hypertrophy and hypertension: causes and consequences. Blood Press Suppl 1995, 2:6-16.
11. Gavras H, Brunner HR, Thurston H, Laragh JH: Reciprocation of renin dependency with sodium volume dependency in renal hypertension. Science 1975, 188:1316-1317.
12. Brown JJ, Davies DL, Morton JJ, et al.: Mechanism of renal hypertension. Lancet 1976, 1:1219-1221.
13. Okamura T, Miyazaki M, Inagami T, Toda N: Vascular renin-angiotensin system in two-kidney, one clip hypertensive rats. Hypertension 1986, 8:560-565.
14. Romero JC, Feldstein AE, Rodriguez-Porcel MG, Cases-Amenos A: New insights into the pathophysiology of renovascular hypertension. Mayo Clin Proc 1997, 72:251-260.
15. Lerman LO, Nath KA, Rodriguez-Porcel M, et al.: Increased oxidative stress in experimental renovascular hypertension. Hypertension 2001, 37:541-546.
16. Inagami T, Mizuno K, Kawamura M, et al.: Localization of components of the renin-angiotensin system within the kidney and sustained release of angiotensins from isolated and perfused kidney. Tohoku J Exp Med 1992, 166:17-26.
17. Lonn EM, Yusuf S, Jha P, et al.: Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation 1994, 90:2056-2069.
18. Higashi Y, Sasaki S, Nakagawa K, et al.: Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 2002, 346:1954-1962.
19. Lonn E, Shaikholeslami R, Yi Q, et al.: Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial. J Am Coll Cardiol 2004, 43:2200-2206.
20. Johansson M, Elam M, Rundqvist B, et al.: Increased sympathetic nerve activity in renovascular hypertension. Circulation 1999, 99:2537-2542.
21. Safian RD, Textor SC:Renal-artery stenosis.N Engl J Med 2001, 344:431-442.
22. Ram CV, Fenves AZ: Hypertension. In Conn's Current Therapy. Edited by Rachel RE. Philadelphia: WB Saunders; 2000:303-315.
23. Zoccali C, Mallamaci F, Finocchiaro P: Atherosclerotic renal artery stenosis: epidemiology, cardiovascular outcomes, and clinical prediction rules. J Am Soc Nephrol 2002, 13:S179-183.
24. Olin JW, Melia M, Young JR, Graor RA, Risius B: Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med 1990, 88:46N-51N.
25. Harding MB, Smith LR, Himmelstein SI, et al.: Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol 1992, 2:1608-1616.
26. Scoble JE: The epidemiology and clinical manifestations of atherosclerotic renal disease. In Renal Vascular Disease. Edited by Novick AC, Scoble J, Hamilton G. London: WB Saunders; 1996:303-314.
27. Crowley JJ, Santos RM, Peter RH, et al.: Progression of renal artery stenosis in patients undergoing cardiac catheterization. Am Heart J 1998, 136:913-918.
28. Caps MT, Perissinotto C, Zierler RE, et al.: Prospective study of atherosclerotic disease progression in the renal artery. Circulation 1998, 98:2866-2872.
29. Schreiber MJ, Pohl MA, Novick AC: The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am 1984, 11:383-392.
30. Sang CN, Whelton PK, Hamper UM, et al.: Etiologic factors in renovascular fibromuscular dysplasia. A case-control study. Hypertension 1989, 14:472-479.
31. Stanley JC, Fry WJ: Pediatric renal artery occlusive disease and renovascular hypertension. Etiology, diagnosis, and operative treatment. Arch Surg 1981, 116:669-676.
32. Goncharenko V, Gerlock AJ Jr, Shaff MI, Hollifield JW: Progression of renal artery fibromuscular dysplasia in 42 patients as seen on angiography. Radiology 1981, 139:45-51.
33. Slovut DP, Olin JW: Fibromuscular dysplasia. N Engl J Med 2004, 350:1862-1871.
34. Malloux LU, Napolitano B, Belluci AG, et al.: Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. Am J Kidney Dis 1994, 24:622-629.
35. Scoble JE, Maher ER, Hamilton G, et al.: Atherosclerotic renovascular disease causing renal impairment - a case for treatment. Clin Nephrol 1989, 31:119-122.
36. Eardley KS, Lipkin GW: Atherosclerotic renal artery stenosis: is it worth diagnosing? J Hum Hypertens 1999, 13:217-220.
37. Textor SC: Ischemic nephropathy: where are we now? J Am Soc Nephrol 2004, 15:1974-1982.
38. Epstein FH: Oxygen and renal metabolism. Kidney Int 1997, 51:381-385.
39. Gobe GC, Axelsen RA, Searle JW. Cellular events in experimental unilateral ischemic renal atrophy and in regeneration after contralateral nephrectomy. Lab Invest 1990, 63:770-779.
40. Suresh M, Laboi P, Mamtora H, Kalra PA: Relationship of renal dysfunction to proximal arterial disease severity in atherosclerotic renovascular disease. Nephrol Dial Transplant 2000, 15:631-636.
41. Cheung CM, Wright JR, Shurrab AE, et al.: Epidemiology of renal dysfunction and patient outcome in atherosclerotic renal artery occlusion. J Am Soc Nephrol 2002, 13:149-157.
42. Krijnen P, van Jaarsveld BC, Steyerberg EW, et al.: A clinical prediction rule for renal artery stenosis. Ann Int Med 1998, 129:705-711.
43. Mann SJ, Pickering TG: Detection of renovascular hypertension. State of the art: 1992. Ann Intern Med 1992, 117:845-853.
44. Zimbler MS, Pickering TG, Sos TA, Laragh JH: Proteinuria in renovascular hypertension and the effects of renal angioplasty. Am J Cardiol 1987, 59:406-408.
45. Gifford RW Jr, McCormack LJ, Poutasse EF: The atrophic kidney: its role in hypertension. Mayo Clin Proc 1965, 40:834-852.
46. Elliott WJ, Martin WB, Murphy MB: Comparison of two non-invasive screening tests for renovascular hypertension. Arch Intern Med 1993, 153:755-764.
47. Postma CT, van der Steen PH, Hoefnagels WH, et al.: The captopril test in the detection of renovascular disease in hypertensive patients. Arch Intern Med 1990, 150:625-628.
48. Liss P, Eklof H, Hellberg O, et al.: Renal effects of CO2 and iodinated contrast media in patients undergoing renovascular intervention: a prospective, randomized study. J Vasc Interv Radiol 2005, 16:57-65.
49. Clark RA, Alexander ES: Digital subtraction angiography of the renal arteries. Prospective comparison with conventional arteriography. Invest Radiol 1983, 18:6-10.
50. Taylor A: Renovascular hypertension: nuclear medicine techniques. Q J Nucl Med 2002, 46:268-282.
51. Radermacher J, Chavan A, Schaffer J, et al.: Detection of significant renal artery stenosis with color Doppler sonography: combining extrarenal and intrarenal approaches to minimize technical failure. Clin Nephrol 2000, 53:333-343.
52. de Haan MW, Kroon AA, Flobbe K, et al.: Renovascular disease in patients with hypertension: detection with duplex ultrasound. J Hum Hypertens 2002, 16:501-507.
53. Vasbinder GB, Nelemans PJ, Kessels AG, et al.: Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Intern Med 2001, 135:401-411.
54. Tan KT, van Beek EJ, Brown PW, et al.: Magnetic resonance angiography for the diagnosis of renal artery stenosis: a meta-analysis. Clin Radiol 2002, 57:617-624.
55. Prokop M: Protocols and future directions in imaging of renal artery stenosis: CT angiography. J Comput Assist Tomogr 1999, 23:S101-S110.
56. Bolduc JP, Oliva VL, Therasse E, et al.: Diagnosis and treatment of renovascular hypertension: a cost-benefit analysis. Am J Roentgenol 2005, 184:931-937.
57. Michaely HJ, Schoenberg SO, Ittrich C, et al.: Renal disease: value of functional magnetic resonance imaging with flow and perfusion measurements. Invest Radiol 2004, 39:698-705.
58. Novick AC, Ziegelbaum M, Vidt DG, et al.: Trends in surgical revascularization for renal artery disease. Ten years' experience. JAMA 1987, 257:498-501.
59. Libertino JA, Bosco PJ, Ying CY, et al.: Renal revascularization to preserve and restore renal function. J Urol 1992, 147:1485-1487.
60. Luscher TF, Keller HM, Imhof HG, et al.: Fibromuscular hyperplasia: extension of the disease and therapeutic outcome. Results of the University Hospital Zurich Cooperative Study on Fibromuscular Hyperplasia. Nephron 1986, 44:109-114.
61. Airoldi F, Palatresi S, Marana I, et al.: Angioplasty of atherosclerotic and fibromuscular renal artery stenosis: time course and predicting factors of the effects on renal function. Am J Hypertens 2000, 13:1210-1217.
62. Birrer M, Do DD, Mahler F, Triller J, Baumgartner I: Treatment of renal artery fibromuscular dysplasia with balloon angioplasty: a prospective follow-up study. Eur J Vasc Endovasc Surg 2002, 23:146-152.
63. de Fraissinette B, Garcier JM, Dieu V, et al.: Percutaneous transluminal angioplasty of dysplastic stenoses of the renal artery: results on 70 adults. Cardiovasc Intervent Radiol 2003, 26:46-51.
64. Zeller T, Frank U, Muller C, et al.: Stent-supported angioplasty of severe atherosclerotic renal artery stenosis preserves renal function and improves blood pressure control: long-term results from a prospective registry of 456 lesions. J Endovasc Ther 2004, 11:95-106.
65. Gill KS, Fowler RC: Atherosclerotic renal arterial stenosis: clinical outcomes of stent placement for hypertension and renal failure. Radiology 2003, 226:821-826.
66. van de Ven PJ, Kaatee R, Beutler JJ, et al.: Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet 1999, 353:282-286.
67. Holden A, Hill A: Renal angioplasty and stenting with distal protection of the main renal artery in ischemic nephropathy: early experience. J Vasc Surg 2003, 38:962-968.
68. van Jaarsveld BC, Krijnen P, Pieterman H, et al.: The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000, 342:1007-1014.
69. Webster J, Marshall F, Abdalla M, et al.: Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 1998, 12:329-335.
70. Plouin PF, Chatellier G, Darne B, Raynaud A: Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 1998, 31:823-829.
71. Bax L, Mali WP, Buskens E, et al.: The benefit of stent placement and blood pressure and lipid-lowering for the prevention of progression of renal dysfunction caused by atherosclerotic ostial stenosis of the renal artery. The STAR-study: rationale and study design. J Nephrol 2003, 16:807-812.
72. The University of Birmingham: ASTRAL: Angioplasty and STent for Renal Artery Lesions. http://www.astral.bham.ac.uk/
73. ClinicalTrials.gov: US National Institutes of Health: Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL). http://www.clinicaltrials.gov/ct/show/NCT00081731